Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Distal membrane-arm assembly complex protein 1 (DMAC1), also known as transmembrane protein 261 (TMEM261) and C9orf123, is a small mitochondrial inner membrane protein required for the assembly and biogenesis of the distal membrane arm of mitochondrial respiratory complex I (NADH:ubiquinone oxidoreductase)[2][3][5]. Loss or knockout of DMAC1 leads to severe defects in complex I assembly and turnover of associated subunits, especially those comprising the ND4 and ND5 modules critical for functional respiratory chain activity[2][5]. DMAC1 is not itself a component of mature complex I, but functions as a transient assembly factor ushering in the correct formation of this essential respiratory enzyme[2][5]. It is not currently recognized as a classical therapeutic target, nor are there drugs or known biomarkers directly associated with it. Its dysfunction may contribute to mitochondrial disorders by impairing energy metabolism through defective complex I assembly[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Distal membrane-arm assembly complex protein 1 (DMAC1).